文献速递肿瘤 PET/CT

18F-DCFPyL PET/CT在前列腺癌生化复发检查中偶然发现滤泡性淋巴瘤摄取

18F-DCFPyL Uptake in an Incidentally Detected Follicular Lymphoma by PET/CT Performed for Biochemically Recurrent Prostate Cancer.
PubMed 文献 · Clin Nucl Med · 2020-01-01

一例75岁前列腺癌患者(初始PSA 27 ng/mL,Gleason 4+5=9,2010年接受外照射放疗联合3年雄激素剥夺治疗)因生化复发(PSA 4.1 ng/mL)于2019年2月行18F-DCFPyL PET/CT,发现盆腔及部分腹主动脉旁淋巴结高摄取,疑为转移;同时偶然发现肠系膜实性肿块及肠系膜淋巴结中度摄取,病理证实为低级别滤泡性淋巴瘤。

要点

  • 18F-DCFPyL PET/CT在前列腺癌生化复发评估中可偶然发现非前列腺恶性肿瘤摄取。
  • 肠系膜肿块及淋巴结中度18F-DCFPyL摄取经病理证实为低级别滤泡性淋巴瘤。
  • 前列腺癌淋巴结转移与偶然发现的淋巴瘤摄取需结合病理鉴别。

核心结论

  • 18F-DCFPyL PET/CT检查中偶然发现的肠系膜病灶摄取经病理证实为低级别滤泡性淋巴瘤。

研究设计与样本

  • 单例病例报告:75岁男性,2010年因前列腺癌(初始PSA 27 ng/mL,Gleason 4+5=9)接受外照射放疗联合3年亮丙瑞林雄激素剥夺治疗。
  • 2019年2月因生化复发(PSA 4.1 ng/mL)行18F-DCFPyL PET/CT检查。

主要发现

  • 盆腔及部分腹主动脉旁淋巴结显示18F-DCFPyL高摄取,疑为转移。
  • 偶然发现肠系膜实性肿块及肠系膜淋巴结显示18F-DCFPyL中度摄取。
  • 肠系膜病灶病理学评估证实为低级别滤泡性淋巴瘤。

临床怎么用

  • 18F-DCFPyL PET/CT读片时需注意前列腺癌预期病灶之外的偶然摄取,必要时行病理活检明确性质。

局限性

  • 单例病例报告,结论外推受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A 75-year-old man, treated with curative intent for histopathologically proven prostate cancer (initial prostate-specific antigen, 27 ng/mL; Gleason 4 + 5 = 9) through external beam radiation therapy in 2010 in combination with 3 years of androgen deprivation therapy (leuprorelin), underwent F-DCFPyL PET/CT for biochemical recurrence with a prostate-specific antigen of 4.1 ng/mL in February 2019. Multiple pelvic and some para-aortic lymph nodes showed highly increased F-DCFPyL uptake, suspicious for metastases. Incidentally, a solid mesenteric mass and mesenteric lymph nodes with moderately increased F-DCFPyL uptake were found. Upon histopathological evaluation, this proved to be a low-grade follicular lymphoma.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Meijer D, Wondergem M, Knol RJJ, et al. 18F-DCFPyL Uptake in an Incidentally Detected Follicular Lymphoma by PET/CT Performed for Biochemically Recurrent Prostate Cancer. Clin Nucl Med. 2020. PMID: 31361646. doi:10.1097/RLU.0000000000002738

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。